BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31284440)

  • 1. Effects of Gut Microbiota on the Bioavailability of Bioactive Compounds from Ginkgo Leaf Extracts.
    Choi MS; Kim JK; Kim DH; Yoo HH
    Metabolites; 2019 Jul; 9(7):. PubMed ID: 31284440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of pharmacokinetic profile of different parts from Ginkgo biloba extract in rats.
    Guan H; Qian D; Ren H; Zhang W; Nie H; Shang E; Duan J
    J Ethnopharmacol; 2014 Aug; 155(1):758-68. PubMed ID: 24953034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VERIFICATION OF AUTHENTICITY OF
    Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
    Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
    [No Abstract]   [Full Text] [Related]  

  • 4. Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota.
    Kim JK; Choi MS; Kim JY; Yu JS; Seo JI; Yoo HH; Kim DH
    Biomed Pharmacother; 2021 Aug; 140():111712. PubMed ID: 34010745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical analysis and quality control of Ginkgo biloba leaves, extracts, and phytopharmaceuticals.
    van Beek TA; Montoro P
    J Chromatogr A; 2009 Mar; 1216(11):2002-32. PubMed ID: 19195661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Ginkgo Folium on antitumor: Bioactive constituents and the potential mechanism.
    Hu D; Wang HJ; Yu LH; Guan ZR; Jiang YP; Hu JH; Yan YX; Zhou ZH; Lou JS
    J Ethnopharmacol; 2024 Mar; 321():117202. PubMed ID: 37742878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative pharmacokinetics and bioavailability of flavonoid glycosides of Ginkgo biloba after a single oral administration of three formulations to healthy volunteers.
    Wójcicki J; Gawrońska-Szklarz B; Bieganowski W; Patalan M; Smulski HK; Samochowiec L; Zakrzewski J
    Mater Med Pol; 1995; 27(4):141-6. PubMed ID: 9000837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of P-glycoprotein in regulating cellular levels of Ginkgo flavonols: quercetin, kaempferol, and isorhamnetin.
    Wang Y; Cao J; Zeng S
    J Pharm Pharmacol; 2005 Jun; 57(6):751-8. PubMed ID: 15969930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a gas chromatographic-mass spectrometric method for simultaneous identification and quantification of marker compounds including bilobalide, ginkgolides and flavonoids in Ginkgo biloba L. extract and pharmaceutical preparations.
    Deng F; Zito SW
    J Chromatogr A; 2003 Jan; 986(1):121-7. PubMed ID: 12585329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans.
    Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R
    Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes.
    Chang TK; Chen J; Teng XW
    Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the bioavailability of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin following single and multiple oral dosing of a hypericum extract containing tablet.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(1):15-22. PubMed ID: 15727160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease.
    Ahlemeyer B; Krieglstein J
    Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginkgo biloba leaf extract (EGb 761®) and its specific acylated flavonol constituents increase dopamine and acetylcholine levels in the rat medial prefrontal cortex: possible implications for the cognitive enhancing properties of EGb 761®.
    Kehr J; Yoshitake S; Ijiri S; Koch E; Nöldner M; Yoshitake T
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S25-34. PubMed ID: 22784425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxicology and carcinogenesis studies of Ginkgo biloba extract (CAS No. 90045-36-6) in F344/N rats and B6C3F1/N mice (Gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2013 Mar; (578):1-183. PubMed ID: 23652021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of pharmacokinetic data of hypericin, pseudohypericin, hyperforin and the flavonoids quercetin and isorhamnetin revealed from single and multiple oral dose studies with a hypericum extract containing tablet in healthy male volunteers.
    Schulz HU; Schürer M; Bässler D; Weiser D
    Arzneimittelforschung; 2005; 55(10):561-8. PubMed ID: 16294501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)].
    Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A
    Therapie; 1995; 50(2):137-44. PubMed ID: 7631288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels and distribution of flavonoids in rat brain after single and repeated doses of standardized Ginkgo biloba extract EGb 761®.
    Rangel-Ordóñez L; Nöldner M; Schubert-Zsilavecz M; Wurglics M
    Planta Med; 2010 Oct; 76(15):1683-90. PubMed ID: 20486074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion.
    Liebgott T; Miollan M; Berchadsky Y; Drieu K; Culcasi M; Pietri S
    Basic Res Cardiol; 2000 Oct; 95(5):368-77. PubMed ID: 11099163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An effective identification and quantification method for Ginkgo biloba flavonol glycosides with targeted evaluation of adulterated products.
    Ma YC; Mani A; Cai Y; Thomson J; Ma J; Peudru F; Chen S; Luo M; Zhang J; Chapman RG; Shi ZT
    Phytomedicine; 2016 Apr; 23(4):377-87. PubMed ID: 27002408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.